What is the Diagnosis?

Qual o Diagnóstico?

  • Eduardo Rodrigues Bento Costa
  • Vagner Rossato Pegoraro
  • Andreza Chaguri Vellenich

Abstract

A female 82-year-old Caucasian patient with a history of paroxysmal atrial fibrillation (AF) for several years, with palpitation crises of varying duration between a few minutes and several hours, without clinical control, using beta-blockers and diltiazem. The patient presented complaints of fatigue on moderate efforts, without precordial pain or syncope, with progressive asthenia and indisposition. She informed three previous hospitalizations for chemical cardioversion of AF.

References

Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20(6):1391-6. https://doi.org/10.1016/0735-1097(92)90253-J

Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10(12):1932-63. https://doi.org/10.1016/j.hrthm.2013.05.014

Antzelevitch C, Yan GX, Ackerman MJ, Borggrefe M, Corrado D, Guoe J. et al. J-Wave syndromes expert consensus conference report: emerging concepts and gaps in knowledge: endorsed by the Asia Pacifi c Heart Rhythm Society (APHRS), the European Heart Rhythm Association (EHRA), the Heart Rhythm Society (HRS), and the Latin American Society of Cardiac Pacing and Electrophysiology (Sociedad Latino-Americana de Estimulación Cardíaca y Electrofi siología [SOLAECE]). Europace 2017;19(4):665-94. https://doi.org/10.1016/j.joa.2016.07.002

Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10(12):1932-63. https://doi.org/10.1016/j.hrthm.2013.05.014

Ramalho DD, Freitas J. Drug-induced life-threatening arrhythmias and sudden cardiac death: A clinical perspective of long QT, short QT and Brugada syndromes. Rev Port Cardiol. 2018;37(5):435-46. https://doi.org/10.1016/j.repc.2017.07.010

Nagayama T, Nagase S, Kamakura T, Wada M, Ishibashi K, Inoue YY, et al. Clinical and Electrocardiographic Diff erences in Brugada Syndrome with Spontaneous or Drug-Induced Type 1 Electrocardiogram. Circ J. 2019;83(3):532-9. https://doi.org/10.1253/circj.

CJ-18-0643

Turker I, Ai T, Itoh H, Horie M. Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes. Pharmacol Ther. 2017;176:48-59. https://doi.org/10.1016/j.pharmthera.2017.05.001

Li L, Ruan Y, Liu N, Zhao O, Zhang M, Li X, et al. “Pill-in-the-Pocket” Treatment of Propafenone Unmasks ECG Brugada Pattern in an Atrial Fibrillation Patient with a Common SCN5A R1193Q Polymorphism. Front Physiol. 2019;10(356):1-8. https://doi.org/10.3389/fphys.2019.00353

Delise P, Allocca G, Sitta N, Migliore F, Dagradi F, Spazzolini C, et al. Cardiac arrest and Brugada syndrome: Is drug-induced type 1 ECG pattern always a marker of low risk? Int J Cardiol. 2018;254:142-145. https://doi.org/10.1016/j.ijcard.2017.10.118

Magalhães LP, Figueiredo MJO, Cintra FD, Saad EB, Kuniyishi RR, Teixeira RA, et al. II Diretrizes Brasileiras de Fibrilação Atrial. Arq Bras Cardiol. 2016;106(4):1-22.

Published
19-10-2019
Section
Clinical Arrythmia